Invivyd is devoted to delivering protection from serious viral infectious diseases
Invivyd is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases.
OUR INVYMAB™ PLATFORM
Leveraging state-of-the-art viral surveillance, predictive modeling, and advanced antibody engineering techniques, we are taking a platform-based approach to the continuous discovery and optimization of monoclonal antibody candidates designed to protect the vulnerable from serious viral threats.
More
Our Pipeline
We are generating a robust pipeline of monoclonal antibody candidates, which could be used in prevention or treatment of serious viral diseases, starting with COVID-19 and expanding into influenza and other high-need indications.
MoreLatest Press Releases
Join Our Team
We are united by a shared commitment to protecting the most vulnerable people in our communities from today’s and tomorrow’s serious viral threats. To address evolving viral threats, we have created a culture that embraces change, nimble decision making, and the relentless pursuit of our mission.
More